After a child is born, the umbilical cord is typically discarded as medical waste. However, scientists have discovered that the umbilical cord is in fact very rich in stem cells. The cord lining is the outermost layer of the umbilical cord and cord tissue is the Wharton's jelly that surrounds the vessels of the umbilical cord. As stem cells from the cord lining and cord tissue are immune-privileged, they hold great promise for regenerative medicine.
 |
: 13 June, 2020 (Saturday) |
 |
: 2:30pm – 4:00pm |
 |
: Zoom Online Meeting |
Program description
- This program is designed to increase awareness of the therapeutic potential of cord lining, cord tissue and cell products.
Learning Objectives
- How cord lining and cord tissue are collected and manufactured.
- The potential application of Mesenchymal Stem Cells (MSCs) and Epithelial Stem Cells (EpSCs).
- How cord lining, cord tissue and cells are being used in clinical trials.
- Current status of COVID-19 stem cell therapy development.
Speakers
A/Professor Phan Toan Thang
Founding Director and Group Chief Scientific Officer
Associate Professor and Principal Investigator of the Wound Healing and Stem Cell Research Group, Department of Surgery, Yong Loo Lin School of Medicine, National University of Singapore.
Adj A/Pro Ivor J Lim
Founding Director and Chief Medical Officer
Organizer: |
 |
Enquiry: |
(852) 39802888
info@hk.cordlife.com |
Please reserve your seat before 6th June, 2020 |
Follow Us